- Home
- CCCC vs GWRS Comparison
CCCC vs GWRS Comparison
Compare CCCC & GWRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCCC
- GWRS
- Stock Information
- Founded
- CCCC 2015
- GWRS 2003
- Country
- CCCC United States
- GWRS United States
- Employees
- CCCC N/A
- GWRS N/A
- Industry
- CCCC Biotechnology: Pharmaceutical Preparations
- GWRS Water Supply
- Sector
- CCCC Health Care
- GWRS Utilities
- Exchange
- CCCC Nasdaq
- GWRS Nasdaq
- Market Cap
- CCCC 104.4M
- GWRS 286.0M
- IPO Year
- CCCC 2020
- GWRS 2010
- Fundamental
- Price
- CCCC $1.48
- GWRS $10.21
- Analyst Decision
- CCCC Buy
- GWRS
- Analyst Count
- CCCC 3
- GWRS 0
- Target Price
- CCCC $12.00
- GWRS N/A
- AVG Volume (30 Days)
- CCCC 1.4M
- GWRS 51.1K
- Earning Date
- CCCC 07-31-2025
- GWRS 08-06-2025
- Dividend Yield
- CCCC N/A
- GWRS 2.99%
- EPS Growth
- CCCC N/A
- GWRS N/A
- EPS
- CCCC N/A
- GWRS 0.23
- Revenue
- CCCC $39,783,000.00
- GWRS $53,539,000.00
- Revenue This Year
- CCCC N/A
- GWRS $8.31
- Revenue Next Year
- CCCC N/A
- GWRS $6.52
- P/E Ratio
- CCCC N/A
- GWRS $44.21
- Revenue Growth
- CCCC 98.56
- GWRS 3.94
- 52 Week Low
- CCCC $1.09
- GWRS $9.37
- 52 Week High
- CCCC $7.66
- GWRS $13.98
- Technical
- Relative Strength Index (RSI)
- CCCC 48.83
- GWRS 45.02
- Support Level
- CCCC $1.36
- GWRS $10.05
- Resistance Level
- CCCC $1.60
- GWRS $10.59
- Average True Range (ATR)
- CCCC 0.12
- GWRS 0.27
- MACD
- CCCC -0.00
- GWRS -0.03
- Stochastic Oscillator
- CCCC 31.58
- GWRS 15.54
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.
About GWRS Global Water Resources Inc.
Global Water Resources Inc operates as a water resources management company that owns, operates, and manages water, wastewater, and recycled water utilities in strategically located communities, principally in metropolitan Phoenix, Arizona. It operates within the State of Arizona.